☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
collaborate
Turning Point and EQRx Collaborate to Evaluate Elzovantinib + Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced NSC...
October 14, 2021
Nestle and Seres Collaborate to Jointly Commercialize SER-109 for Recurrent Clostridioides difficile Infection
July 2, 2021
BridgeBio Collaborates with Helsinn to Co- Develop and Commercialize Infigratinib in Oncology
April 1, 2021
Samsung Bioepis and Yuhan Collaborate for the Commercialization of Adalloce (biosimilar- adalimumab) in Korea
March 15, 2021
UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development
February 25, 2021
Novartis Collaborates with Bill & Melinda Gates Foundation to Discover and Develop Gene Therapy for Sickle Cell Disease
February 18, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.